Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (3.6), the stock would be worth ¥42.33 (6% upside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 3.4 | ¥40.05 |
0%
|
| 3-Year Average | 3.6 | ¥42.33 |
+6%
|
| 5-Year Average | 3.6 | ¥42.58 |
+6%
|
| Industry Average | 2.3 | ¥26.73 |
-33%
|
| Country Average | 2.4 | ¥28.86 |
-28%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
|
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
|
12.9B CNY | 3.4 | 13.8 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
102.7B USD | -79.1 | 23.7 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
60.7B USD | 31.8 | 37.4 | |
| US |
|
Cencora Inc
NYSE:COR
|
60.7B USD | 31.8 | 37.4 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
48.5B USD | -16.8 | 29.2 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
31.6B AUD | 6.5 | 35.1 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
62.8B CNY | 0.8 | 11 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.8B USD | 2.7 | 22.1 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
59.2B CNY | 2.5 | 20.9 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 6 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
57.5B HKD | 0.6 | 7.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.5 |
| Median | 2.4 |
| 70th Percentile | 3.9 |
| Max | 1 172 445.9 |
Other Multiples
Tibet Rhodiola Pharmaceutical Holding Co
Glance View
Tibet Rhodiola Pharmaceutical Holding Co., nestled in the sprawling and mystical landscape of Tibet, is a beacon of traditional Chinese medicine intertwined with contemporary pharmaceutical practices. The company's genesis lies in the rich, indigenous knowledge of the Rhodiola plant, revered for its supposed adaptogenic properties, which potentially aid in combating stress and fatigue. The plant flourishes in the harsh, high-altitude environment of the Tibetan Plateau, and Tibet Rhodiola has adeptly harnessed both its historical and geographical advantages to cultivate, extract, and process Rhodiola into various health products. These formulations, which range from dietary supplements to wellness solutions, reflect a marriage of ancient herbal wisdom with modern scientific methodologies. Central to the company's business model is its vertically integrated supply chain, which allows it to oversee and control every aspect of production—from the sustainable harvesting of Rhodiola to its research and development ventures. This integration not only ensures quality and efficacy but also fortifies the company's brand as a trustworthy entity within the competitive herbal supplements market. By expanding its distribution channels, Tibet Rhodiola has successfully entered both domestic and international markets, leveraging the rising global enthusiasm for natural and holistic healthcare solutions. This strategic movement feeds directly into its revenue system, which thrives on the growing demand for health products that claim to support vitality and resilience, mirroring the age-old allure of Tibetan medicinal practices.